Schedule 13G ownership disclosure

XILIO THERAPEUTICS INC

Common Stock, par value $0.0001 per share · CUSIP: 98422T100

Event date: 2025-12-31

Filing-level shares
14,517,678
Percent of class
19.9%
  • GILEAD SCIENCES, INC.

    Shares: 14,517,678 · Class: 19.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001123292-26-000166
Form type
SCHEDULE 13G/A
Filer
GILEAD SCIENCES, INC.
CIK
CIK 882095
Filed
Feb 12, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub